Skip to main content

Advertisement

ADVERTISEMENT

Column

Editor's Page
08/20/2021
Winston Wong, PharmD
Winston Wong, PharmD, discusses the articles in this issue, which include research examining the impact of a SARS-CoV-2 infection on patients previously diagnosed with immune-mediated inflammatory diseases, and results from a study examining...
Winston Wong, PharmD, discusses the articles in this issue, which include research examining the impact of a SARS-CoV-2 infection on patients previously diagnosed with immune-mediated inflammatory diseases, and results from a study examining...
Winston Wong, PharmD, discusses...
08/20/2021
Journal of Clinical Pathways

Advertisement

COA Viewpoint
08/19/2021
Ricky Newton, CPA, chief financial & operating officer, Community Oncology Alliance
Ricky Newton, CPA, weighs in on states seeking to enact legislation regulating pharmacy benefit managers, which he describes as the "next frontier" in the ongoing war with the pharmacy benefit managers.
Ricky Newton, CPA, weighs in on states seeking to enact legislation regulating pharmacy benefit managers, which he describes as the "next frontier" in the ongoing war with the pharmacy benefit managers.
Ricky Newton, CPA, weighs in on...
08/19/2021
Journal of Clinical Pathways
Clinical Pathways GPS
08/19/2021
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...
08/19/2021
Journal of Clinical Pathways
Pharma Insights
08/19/2021
Marlon Graf, PhD
Rifat Tuly, MPH
Suepattra G May, MPH, PhD
Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.
Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.
Marlon Graf, PhD, and colleagues...
08/19/2021
Journal of Clinical Pathways

Advertisement

Trending From ACCC
08/19/2021
Association of Community Cancer Centers
The Association of Community Cancer Centers discuss how conducting a geriatric assessment can help uncover the comorbidities and age-related vulnerabilities that can impact cancer treatment in older adults.
The Association of Community Cancer Centers discuss how conducting a geriatric assessment can help uncover the comorbidities and age-related vulnerabilities that can impact cancer treatment in older adults.
The Association of Community...
08/19/2021
Journal of Clinical Pathways
Trending From ACCC
06/22/2021
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways....
06/22/2021
Journal of Clinical Pathways
COA Viewpoint
06/22/2021
Mark Thompson, MD, medical director of public policy, Community Oncology Alliance
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses...
06/22/2021
Journal of Clinical Pathways

Advertisement

Editor's Page
06/22/2021
Winston Wong, PharmD
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses...
06/22/2021
Journal of Clinical Pathways
Pharma Insights
06/21/2021
Maureen Hennessey, PhD, CPCC, CPHQ
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC,...
06/21/2021
Journal of Clinical Pathways
Trending From ACCC
05/19/2021
The Association of Community Cancer Centers begins an initiative to gain insights from Alternative Payment Models’ (APMs) impact on cancer care, Facilitate collaboration and sharing of experiences between cancer programs and practices related...
The Association of Community Cancer Centers begins an initiative to gain insights from Alternative Payment Models’ (APMs) impact on cancer care, Facilitate collaboration and sharing of experiences between cancer programs and practices related...
The Association of Community...
05/19/2021
Journal of Clinical Pathways

Advertisement

Advertisement